Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data

Individuals with autoimmune rheumatic disease (RD) are considered to be at increased risk for infection. However, few US population‐based studies have assessed whether these patients are at increased risk of hospitalization or death due to COVID‐19 compared with those without RD.

[1]  K. Michaud,et al.  Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals , 2021, Arthritis & rheumatology.

[2]  C. Turesson,et al.  Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study , 2021, Annals of the Rheumatic Diseases.

[3]  L. Trupin,et al.  Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry , 2021, Annals of the Rheumatic Diseases.

[4]  C. Torp‐Pedersen,et al.  Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark , 2020, Rheumatology.

[5]  Hyon K. Choi,et al.  COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study , 2020, Arthritis & rheumatology.

[6]  Florence Nassim Jean-David Didier Yannick Blanca Zahir Emma Aeschlimann Ait-Abdallah Albert Alcais A.  Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients , 2020, Annals of the Rheumatic Diseases.

[7]  R. Hubbard,et al.  Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic , 2020, Rheumatology.

[8]  L. Trupin,et al.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry , 2020, Annals of the Rheumatic Diseases.

[9]  T. Iwashyna,et al.  Using Veterans Affairs Corporate Data Warehouse to identify 30-day hospital readmissions , 2018, Health Services and Outcomes Research Methodology.

[10]  J. Yazdany,et al.  Underestimation of the Reliability of Codes for Rheumatoid Arthritis Within Administrative Data: Comment on the Article by Ng et al , 2013, Arthritis care & research.